Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK10 | P53779 | 1/20 | 0.42 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.42 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | HPGD | P15428 | 4/20 | 0.41 |
| ▸ | ELANE | P08246 | 1/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
| ▸ | MYC | P01106 | 1/20 | 0.40 |
| ▸ | MAX | P61244 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.39 |
| ▸ | POLB | P06746 | 3/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.39 |
| ▸ | CASP1 | P29466 | 2/20 | 0.39 |
| ▸ | CASP7 | P55210 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | RECQL | P46063 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29588824 | 1.00 | MAPK10 (0.42) | MAPK10RIPK1ADORA2AKDM4EALDH1A1 | |
| SCHEMBL27222336 | 0.91 | ADORA2A (0.39) | MAPK10RIPK1ADORA2AKDM4EALDH1A1 | |
| SCHEMBL6708105 | 0.87 | ALDH1A1 (0.43) | ADORA2AKDM4EALDH1A1HPGDELANE | |
| SCHEMBL3295735 | 0.79 | ALDH1A1 (0.37) | ADORA2AKDM4EALDH1A1HPGDELANE | |
| SCHEMBL4499241 | 0.77 | MAPK10 (0.45) | MAPK10RIPK1ADORA2AKDM4EALDH1A1 | |
| SCHEMBL5229303 | 0.76 | KDM4E (0.40) | KDM4EALDH1A1HPGDELANENPSR1 | |
| SCHEMBL4501863 | 0.75 | CDK4 (0.44) | ADORA2AKDM4EALDH1A1HPGDELANE | |
| SCHEMBL5407353 | 0.75 | POLB (0.44) | KDM4EALDH1A1TDP1POLBL3MBTL1 | |
| Cinnamic Acid SCHEMBL5806210 | 0.74 | HCAR2 (0.43) | KDM4EALDH1A1ELANEPOLBL3MBTL1 | |
| SCHEMBL29957486 | 0.73 | MAPT (0.41) | MAPK10KDM4EALDH1A1HPGDNPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 97 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240167081-A1 | IMMOBILIZATION METHODS AND COMPOSITIONS FOR IN SITU DETECTION | 10X GENOMICS, INC. | 2024-05-23 | — | — | US | claimed |
| WO-2024102736-A1 | IMMOBILIZATION METHODS AND COMPOSITIONS FOR IN SITU DETECTION | 10X GENOMICS, INC. (US) | 2024-05-16 | — | — | WO | claimed |
| EP-4363611-A1 | COMPOSITIONS AND METHODS FOR ENRICHMENT OF NUCLEIC ACIDS USING LIGHT-MEDIATED CROSS-LINKING | Dana-Farber Cancer Institute, Inc. (US) | 2024-05-08 | — | — | EP | claimed |
| CN-117700419-A | Nitric oxide donor carbazole derivatives and their use in the treatment of neoplastic diseases | 中国医学科学院药物研究所 | 2024-03-15 | — | — | CN | claimed |
| CN-114685519-B | Pyranocarbazole alkaloid derivatives and application thereof in treating Alzheimer's disease | 中国医学科学院药物研究所 | 2023-09-26 | — | — | CN | claimed |
| CN-113214275-B | Pyranocarbazole alkaloid derivative and application thereof in treating nervous system diseases | 中国医学科学院药物研究所 | 2023-09-26 | — | — | CN | claimed |
| WO-2023278704-A1 | COMPOSITIONS AND METHODS FOR ENRICHMENT OF NUCLEIC ACIDS USING LIGHT-MEDIATED CROSS-LINKING | DANA-FARBER CANCER INSTITUTE, INC. (US) | 2023-01-05 | — | — | WO | claimed |
| US-20220372570-A1 | CONTROLLED CROSSLINKING OF BIOMOLECUES IN SITU | 10X GENOMICS, INC. | 2022-11-24 | — | — | US | claimed |
| CN-114685519-A | Pyrano-carbazole alkaloid derivative and application thereof in treating Alzheimer's disease | 中国医学科学院药物研究所 | 2022-07-01 | — | — | CN | claimed |
| CN-112961165-B | Carbazole benzopyran compound and application thereof | 同济大学 | 2022-02-01 | — | — | CN | claimed |
| CN-113214275-A | Pyranocarbazole alkaloid derivatives and their use for treating nervous system diseases | 中国医学科学院药物研究所 | 2021-08-06 | — | — | CN | claimed |
| CN-112961165-A | Preparation and application of novel carbazole benzopyran compound | 同济大学 | 2021-06-15 | — | — | CN | claimed |
| WO-2020254672-A1 | SPATIAL CHARACTERISATION OF TARGET STRUCTURES IN A SAMPLE | THERYCELL GMBH (DE) | 2020-12-24 | — | — | WO | claimed |
| US-20260132458-A1 | SYSTEMS AND METHODS FOR NUCLEIC ACID MISMATCH ERROR DETECTION | ULTIMA GENOMICS INC (US) | 2026-05-14 | — | — | US | disclosed |
| WO-2026052031-A1 | CARBAZOLE DERIVATIVE AND USE THEREOF | 中国医学科学院药物研究所 | 2026-03-12 | — | — | WO | disclosed |
| CN-121627709-A | Carbazole derivative and application thereof | 中国医学科学院药物研究所 | 2026-03-10 | — | — | CN | disclosed |
| EP-0975624-A1 | THERMOGENIC COMPOSITION AND BENZAZEPINE THERMOGENICS | Takeda Chemical Industries, Ltd. (JP) | 2000-02-02 | — | — | EP | disclosed |
| WO-1998046590-A1 | THERMOGENIC COMPOSITION AND BENZAZEPINE THERMOGENICS | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1998-10-22 | — | — | WO | disclosed |
| US-5620973-A | CHOLINESTERASE INHIBITOR; ALZHEIMER*S DISEASE | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1997-04-15 | — | — | US | disclosed |
| EP-0655451-A1 | Tetracyclic condensed heterocyclic compounds for the treatment of senile dementia | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1995-05-31 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260132458-A1 | SYSTEMS AND METHODS FOR NUCLEIC ACID MISMATCH ERROR DETECTION | UBE2V1, MCTS1, MICA | MAPK10 2864/4885RIPK1 4061/4885ADORA2A 1554/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.